Loading
过去 90 天内没有内部人买入。最近一笔披露于 2026年3月09日。
eHealth, Inc.：高管交易动态
eHealth, Inc.归属医疗与制药行业。公司董事和高级管理人员通过SEC (Form 4)申报交易。过去一年（2025年10月18日至2026年10月18日），共有43份申报出自10位高管。
在市场上，2位高管买入（2笔买入，合计€25.3万），同时1位高管卖出（2笔卖出，合计€2.5万）。总体来看，高管净买入€22.8万。公开市场买入是最受关注的申报类型，因为高管是用自己的钱购买股份。买入者中有1位首席财务官和1位首席执行官。年内最大一笔：€22.0万，由Duke Derrick A买入，于2026年3月2日公开。
就1笔买入而言，公司另一位高管也在同一30天内买入。多位不同高管在短时间内买入同一只股票，称为集群买入，这种情形比单笔买入更受研究者关注。有记录的最近一笔买入公布于2026年3月9日，即223天前。从交易发生到出现在SEC (Form 4)的披露中，中位时长为3天。第16条规则给予每份Form 4表格两个工作日的提交时间。
十二个月内共43份申报，高于我们在同一交易所跟踪的5,810家公司的中位数（19份申报）。自2021年以来，数据库收录了公司高管的19笔买入和5笔卖出。根据10-K年报，截至2025年12月31日的财年营收达5.54亿 USD，净利润为4004.4万 USD。
同一行业的其他公司中，我们的信号近期发现了MAIA Biotechnology, Inc.和Cooper Companies, Inc.的高管买入。以上数据均来自SEC (Form 4)发布的申报，描述的是过去的情况，不代表未来股价走势，也不构成投资建议。
高管申报
256
持股线
暂无
买入金额
€260万
19 笔 · 全部历史
卖出金额
€132,715
5 笔 · 全部历史
谁在何时交易
买入卖出FRANCIS S. SOISTMAN Jr.2 笔卖出
Derrick A. Duke1 笔买入
Gavin G. Galimi1 笔买入
John Joseph Dolan1 笔买入
Wolf Dale B1 笔卖出
内部人买入以来
- +3.7%入场价 US$1.62 · T+90 收盘 US$1.68
- +5.1%入场价 US$1.56 · T+90 收盘 US$1.64
- -62.1%入场价 US$4.33 · T+365 收盘 US$1.64
入场价为披露次日收盘价，即读者可操作的第一个价格。价格以上市货币计。过往涨跌不代表未来表现。
该评分只在所属市场内对买入进行排名。仅在经过回测的策略范围内的交易所提供建议仓位；其他市场的信号仍处于观察状态。并非投资建议。
基本面评分
在 24,148 家已排名公司中位列第 11,931
51.9
评分 / 100
价值52
质量52
FCF 收益率·
盈利收益率-55%
EV/EBITDA1.8x
ROE2.9%
毛利率96%
净利率-1.9%
负债/EBITDA1.6x
支柱2/3
透明的价值 + 质量排名，独立于内部人交易信号。
财务数据
财年 2025财年截至 2025年12月 · cache
US$0.70
分析师一致预期
4 位分析师3.00/5
US$1.50目标价 US$1.81(+159%)US$2.00
利润表
营业收入US$554M
毛利US$530.6M96% 利润率
EBITDAUS$83.2M15% 利润率
净利润-US$10.4M5.4% 利润率
估值
PER (forward)0.6x
P/Book0.0x
贝塔1.63
资产负债与现金
市值US$22.4M
总负债US$134.4M
自由现金流-US$40.7M
负债 / 股东权益14%
盈利能力与股权结构
ROE2.9%
ROA3.4%
内部人持股 %7.6%
机构持股 %51.1%
最新申报日期：2026年10月13日
申报256 总计
842 股@ US$0.70股票SEC:0001950061-26-000021:0
323 股@ US$0.70股票SEC:0002005261-26-000023:0
465 股@ US$0.70股票SEC:0001931967-26-000025:0
20,306 股@ US$0.69130.062% 占市值100.0% 占其流量股票SEC144:0001950047-26-009994
20,306 股@ US$0.69620.062% 占市值0.4% 占其流量股票SEC:0001233184-26-000019:0
20,306 股@ US$0.69130.062% 占市值0.4% 占其流量股票SEC:0001233184-26-000019:1
20,306 股@ US$0.69620.062% 占市值25.4% 占其流量股票SEC144:0001950047-26-009925
4,312 股@ US$0.920.016% 占市值1.7% 占其流量股票SEC:0002005261-26-000021:0
5,859 股@ US$0.920.022% 占市值1.7% 占其流量股票SEC:0001931967-26-000023:0
70,000 股0股票SEC:0002005261-26-000019:0
70,000 股0股票SEC:0001931967-26-000021:0
60,000 股0股票SEC:0001950061-26-000019:0
37,296 股@ US$1.13770.17% 占市值100.0% 占其流量股票SEC144:0001950047-26-008871
24,350 股@ US$1.420.14% 占市值12.0% 占其流量股票SEC:0001499498-26-000006:0
465 股@ US$1.620.0031% 占市值0.2% 占其流量股票SEC:0001931967-26-000019:0
841 股@ US$1.620.0056% 占市值0.3% 占其流量股票SEC:0001950061-26-000017:0
323 股@ US$1.620.0021% 占市值0.2% 占其流量股票SEC:0002005261-26-000017:0
61,041 股股票SEC:0001509185-26-000002:0
61,041 股股票SEC:0001793004-26-000008:0
61,041 股股票SEC:0001786769-26-000009:0
4,311 股股票SEC:0002005261-26-000015:0
3,588 股@ US$1.890.013% 占市值1.4% 占其流量股票SEC:0001950061-26-000013:0
3,571 股@ US$1.890.017% 占市值2.8% 占其流量股票SEC:0002005261-26-000013:0
4,206 股@ US$1.890.015% 占市值2.6% 占其流量股票SEC:0001931967-26-000015:0
323 股@ US$1.320.0011% 占市值0.2% 占其流量股票SEC:0002005261-26-000011:0
256 条申报中的 25 条
About eHealth, Inc.
eHealth, Inc. (Nasdaq: EHTH) is a U.S.-based online health insurance distribution platform. The company is headquartered in Austin, Texas, and was incorporated in Delaware in November 1997. It built one of the early digital marketplaces for health insurance in the United States, allowing consumers to research, compare, and enroll in coverage online. For French-speaking investors, the key point is that eHealth is listed on the Nasdaq market in the United States, so it trades as a U.S. healthcare services/platform name rather than as a traditional balance-sheet insurance carrier.
The company’s core business is health insurance brokerage and consumer guidance. Over time, eHealth has become particularly associated with Medicare, while still serving other insurance segments. Its main product lines include Medicare Advantage, Medicare Supplement, and Medicare Part D plans, as well as individual and family coverage, small-business plans, and selected ancillary products. The company positions itself as a carrier-agnostic marketplace, meaning it presents offerings from multiple insurance partners so consumers can evaluate options side by side. eHealth also emphasizes its digital platform, licensed benefit advisors, data integration, AI, analytics, and tools that support customer acquisition and enrollment.
展开全文收起
From a competitive standpoint, eHealth operates in a crowded and heavily regulated market. Its performance is influenced by Medicare enrollment cycles, ACA-related activity, carrier pricing and plan design changes, and competition from other digital distribution channels, insurance agents, and government-sponsored platforms. The company’s strategic strengths are its brand recognition, long operating history, carrier relationships, omnichannel enrollment capabilities, and the ability to guide consumers through a complex purchasing process. Management has also highlighted efforts to build lifelong customer relationships, which suggests a more recurring, relationship-driven model than a one-off lead generation business.
Recent developments have been material. In January 2026, eHealth announced a new $125 million asset-based revolving credit facility to strengthen its capital structure and repay existing debt. In February 2026, the company unveiled a new growth strategy focused on trusted, lifelong customer relationships and on serving consumers across Medicare, ACA, and employer-sponsored ICHRA coverage needs. In May 2026, eHealth reported first-quarter 2026 results, following a 2024 that showed improved profitability and stronger Medicare-related volumes. The broader investment case therefore centers on execution in Medicare, the durability of its digital distribution model, and the company’s ability to manage leverage while expanding its platform-based healthcare insurance franchise in the United States.
